St Jude Medical Inc (STJ)

STJ (NYSE:Health Services) EQUITY
$79.02
pos +0.00
+0.00%
Today's Range: 78.78 - 79.25 | STJ Avg Daily Volume: 2,406,300
Last Update: 12/02/16 - 4:02 PM EST
Volume: 0
YTD Performance: 28.22%
Open: $0.00
Previous Close: $78.78
52 Week Range: $48.83 - $84.00
Oustanding Shares: 285,716,462
Market Cap: 22,508,742,876
6-Month Chart
TheStreet Ratings Grade for STJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 18 18 17 17
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.89 2.89 2.89 2.89
Latest Dividend: 0.31
Latest Dividend Yield: 1.57%
Dividend Ex-Date: 09/28/16
Price Earnings Ratio: 34.55
Price Earnings Comparisons:
STJ Sector Avg. S&P 500
34.55 34.60 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.72% 25.23% 35.57%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.40 0.00 0.00
Net Income -9.30 0.10 0.05
EPS -11.30 0.30 0.09
Earnings for STJ:
EBITDA 1.49B
Revenue 5.54B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.06 $0.99 $4.02 $4.40
Number of Analysts 16 11 17 17
High Estimate $1.12 $1.03 $4.09 $4.60
Low Estimate $1.02 $0.87 $3.97 $4.08
Prior Year $1.02 $0.90 $3.94 $4.02
Growth Rate (Year over Year) 4.04% 9.70% 1.96% 9.45%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Oct 19, 2016 | 11:55 AM EDT
Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.
RMPIA
By

Jim Cramer

 | Oct 11, 2016 | 2:44 PM EDT
On days like this, the money just keeps sloshing around.
By

Jim Cramer

 | Oct 11, 2016 | 12:40 PM EDT
St. Jude's warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs.
By

James Passeri

 | Oct 11, 2016 | 8:32 AM EDT
Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.
RMPIA
By

Robert Lang

 | Oct 3, 2016 | 11:00 AM EDT
Despite markets at record highs, companies are satisfying their appetites to grow and find value by buying others.
By

Tim Melvin

 | Sep 13, 2016 | 2:00 PM EDT
These sectors are full of high-priced, low-growth stocks.
By

Jim Cramer

 | Aug 29, 2016 | 11:20 AM EDT
Jim Cramer says whether or not Abbott completes its acquisition of St. Jude remains to be seen.
By

James Passeri

 | Aug 25, 2016 | 2:30 PM EDT
Data-storage companies got a boost on news a supply shortage could be looming.
By

Jim Cramer

 | Apr 28, 2016 | 1:14 PM EDT

The M&A activity is an incredible and a welcome sign.

RMPIA
By

Jim Cramer

 | Apr 28, 2016 | 10:57 AM EDT
Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.